Reports have theorized that levetiracetam can enhance expression of p53, increase binding of histone deacetylase-1 (HDAC1) complex to the MGMT promoter complex, and sensitize GBM cells to TMZ [58]. This evidence concerns the gene MGMT and glioblastoma.